Taiwan recalls asthma drug Nucala Solution for Injection as precaution

Taiwan's Food and Drug Administration (FDA) said Monday that as a precautionary measure, it has ordered the recall of a batch of Nucala Solution for Injection, a prescription medicine used to treat severe asthma, because of a potential quality defect.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)